As an increasingly diverse array of ADCs containing different payloads and linkers are developed to tackle different tumour targets, understanding how bioconjugate design contributes and accumulates to performance, especially in the clinic, is vital to set up your therapy for success

Take part in this workshop exploring case-study examples to contextualise and understand the performance of different ADC designs to understand what really makes a clinically effective ADC

Workshop highlights include:

• Accurately correlating and characterising antibody, linker, payload, and overall conjugate contributions to ADC clinical performance
• Delving into ADC clinical case studies to understand differentiated design impact on clinical safety and efficacy profiles
• Finding the right match: optimising ADC design to optimise payload target pairing